$2.17 0.01 (+0.24%)
2/13/2012 10:05 AM

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Featured Broker Partners


Advertisement